May 14th, 2018
Beam Therapeutics launched to develop Harvard base editing technology toward precision genetic medicines
Harvard innovations enable the correction of single-base mutations in DNA with unprecedented precision and efficiency
News
Press Contact: Kirsten Mabry | (617) 495-4157
Featured Tags:
May 14th, 2018
Harvard innovations enable the correction of single-base mutations in DNA with unprecedented precision and efficiency
May 3rd, 2018
OTD’s Guppy Tank series connects life-science innovators with industry veterans
April 30th, 2018
Innovations in slippery surfaces, biomaterials to modulate immune response, anti-counterfeiting, metalenses, inhibitors of cellular necrosis, bacterial delivery of polypeptides, and more
April 23rd, 2018
New molecular strategy enriches multiple disease-related rare genetic DNA variants with high accuracy in a single assay to enable personalized diagnosis and treatments
April 3rd, 2018
Multi-year Harvard research collaboration with Aetna will assess well-being across numerous dimensions of health and wholeness